Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$36.7M
-15.1% from 2023
Prescriptions
62K
$596.35 per claim
Patients
16K
15,793 prescribers
Total spending, 2024
$36.8M
$2,327.47 per patient
Medicare prescription drug plans paid $36.7M for Serevent Diskus in 2024, for 61,617 prescriptions and refills to 15,789 patients (down 15.1% from 2023). The average cost per claim was $596.35.
California had the highest Medicare cost for Serevent Diskus in 2024: $4.4M for 7,095 claims, followed by Washington ($2.2M).
Sunil Arora, internal medicine in San Bernardino, CA, had the highest Medicare cost for Serevent Diskus in 2024: 142 claims costing $60K.
Serevent Diskus is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sunil Arora San Bernardino, CA | Internal Medicine | 142 | 34 | $60K |
| Mark D Weissig Fullerton, CA | Pulmonary Disease | 79 | 25 | $52K |
| Francis V Adams |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 18,052 | 75,302 | 18,644 | $47.6M |
| 2023 | 17,118 | 68,096 | 17,305 | $43.3M |
| 2024 | 15,793 | 61,617 | 15,789 | $36.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 77 |
| 20 |
| $49K |
| Michael Schatz San Diego, CA | Allergy/ Immunology | 37 | 12 | $47K |
| David Kaminsky Burlington, VT | Internal Medicine | 34 | Under 11 | $31K |
| Jason B Karp Lake Success, NY | Pulmonary Disease | 40 | 12 | $29K |
| Alison M Beer Bellingham, WA | Pulmonary Disease | 62 | 11 | $29K |
| Parissa Vassef Long Beach, CA | Neurology | 56 | 17 | $27K |
| Matthew R Montoya Albuquerque, NM | Pulmonary Disease | 43 | 15 | $26K |
| Daniel J Markley Summit, NJ | Pulmonary Disease | 36 | Under 11 | $24K |
| Roger K Eagan Bremerton, WA | Pulmonary Disease | 20 | Under 11 | $24K |
| John M Wengryn Plymouth, MA | Pulmonary Disease | 44 | Under 11 | $23K |
| Johnathan R Grant Vincennes, IN | Pulmonary Disease | 41 | Under 11 | $21K |
| Denzil M Reid Westfield, MA | Pulmonary Disease | 41 | Under 11 | $21K |
| Wendy B Gilraine Martinsville, VA | Nurse Practitioner | 50 | Under 11 | $21K |
| Julia A Miller Johnson City, NY | Pulmonary Disease | 17 | Under 11 | $21K |
| Peter H Law Memphis, TN | Pulmonary Disease | 34 | Under 11 | $20K |
| Gregory P Lemense Bozeman, MT | Pulmonary Disease | 31 | Under 11 | $20K |
| Sin Wee Koh-Gale Rancho Mirage, CA | Nurse Practitioner | 30 | Under 11 | $19K |
| Ganesha Santhyadka Bangor, ME | Pulmonary Disease | 32 | Under 11 | $19K |
| Richard N Read Manchester, NH | Pulmonary Disease | 27 | Under 11 | $18K |
| Michel R Samaha Milford, DE | Pulmonary Disease | 36 | Under 11 | $17K |
| Daniel J Allen Middleton, ID | Family Practice | 36 | Under 11 | $16K |
| Richard W Rissmiller Jr. Charleston, SC | Pulmonary Disease | 21 | Under 11 | $16K |
| Stanislav V Belyaev Roswell, NM | Pulmonary Disease | 36 | Under 11 | $16K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline GSK | 61,638 | $36.8M |